Skip to main content
. Author manuscript; available in PMC: 2013 Jun 21.
Published in final edited form as: Brain Res. 2012 Apr 21;1461:76–86. doi: 10.1016/j.brainres.2012.04.024

Table 3.

Total lesion
(% contralateral hemisphere)		 Cystic component
(% total lesion)
P E2, 0.18 mg E2, 0.72 mg P E2, 0.18 mg E2, 0.72 mg
H&E 37±18
(n=11)		 42±8
(n=7)		 41±19
(n=11)		 61±28
(n=11)		 29±17
(n=7)		 30 ±12*
(n=11)
MRI 43.2 ± 4.9
(n=3)		 nd 38.4±5.5
(n=4)		 55.3±3.8
(n=3)		 nd 32.4±12.5**
(n=4)

H&E: hematoxylin and eosin; MRI: magnetic resonance imaging; nd = not determined

*

ANOVA, p=0.008 for P vs. E2, 0.18 and P vs. E2, 0.72.

**

Student’s t-test, p=0.03 for P vs.E2, 0.72.